The SOX Trial: Compression Stockings to Prevent the Post-Thrombotic Syndrome
Launched by SIR MORTIMER B. DAVIS - JEWISH GENERAL HOSPITAL · Sep 1, 2005
Trial Information
Current as of August 25, 2025
Completed
Keywords
ClinConnect Summary
The post-thrombotic syndrome (PTS) is a frequent, burdensome and costly condition that occurs in about one third of patients after an episode of deep vein thrombosis (DVT). Affected patients have chronic leg pain and swelling, and sometimes develop skin ulcers. At present, there is little to offer for the treatment of this condition. Prevention of PTS is the key to reducing its burden on patients and society. Elastic compression stockings (ECS) could be helpful in preventing PTS, however data on their effectiveness are scarce and conflicting.
Comparison(s): Knee-length, 30-40 mm Hg (Class ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Consecutive patients with a first, symptomatic, objectively confirmed proximal DVT diagnosed within the last 14 days (with or without concurrent distal DVT or pulmonary embolism)
- • Who have no contraindications to standard treatment with heparin and/or warfarin, and
- • Who provide informed consent to participate
- Exclusion Criteria:
- • Contraindication to compression stockings
- • Limited lifespan (estimated \< 6 months)
- • Geographic inaccessibility preventing return for follow-up visits
- • Inability to apply stockings daily and unavailability of a caregiver to apply stockings daily
- • Treatment of acute DVT with thrombolytic agents
About Sir Mortimer B. Davis Jewish General Hospital
Sir Mortimer B. Davis – Jewish General Hospital is a leading academic medical center located in Montreal, Canada, renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical research, the hospital integrates cutting-edge scientific inquiry with comprehensive patient care, focusing on a range of medical disciplines to enhance treatment outcomes and improve patient quality of life. With a strong emphasis on collaboration, ethics, and community engagement, the hospital strives to foster a research environment that promotes discovery and translates findings into effective therapeutic solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Durham, North Carolina, United States
Montreal, Quebec, Canada
Winnipeg, Manitoba, Canada
London, Ontario, Canada
Oklahoma City, Oklahoma, United States
Montreal, Quebec, Canada
Toronto, Ontario, Canada
Toronto, Ontario, Canada
Victoria, British Columbia, Canada
Detroit, Michigan, United States
Halifax, Nova Scotia, Canada
Hamilton, Ontario, Canada
Hamilton, Ontario, Canada
Hamilton, Ontario, Canada
Hamilton, Ontario, Canada
Hamilton, Ontario, Canada
Ottawa, Ontario, Canada
Longueuil, Quebec, Canada
Montreal, Quebec, Canada
Montreal, Quebec, Canada
Montreal, Quebec, Canada
Montreal, Quebec, Canada
Montreal, Quebec, Canada
Montreal, Quebec, Canada
Quebec City, Quebec, Canada
Patients applied
Trial Officials
Susan R. Kahn, M.D., M.Sc.
Principal Investigator
Sir Mortimer B. Davis - Jewish General Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials